Effects of Exercise Training on Cardiovascular Health in Middle-aged Women

August 14, 2018 updated by: Ylva Hellsten, University of Copenhagen
The hypothesis of the present study is that physical training can oppose detrimental changes in cardiovascular and metabolic health associated with estrogen loss after menopause.

Study Overview

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Copenhagen, Denmark
        • University of Copenhagen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 57 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Premenopausal (45-53 years) OR postmenopausal 50-57 years
  • BMI> 18.5 and <30
  • Sedentary (no regular physical activity the last 2 years)
  • Plasma measurements
  • Premenopausal: estradiol> 0.20 nmol/l, Follicle stimulating hormone < 22 IU/l and progesterone >2.5 nmol/l
  • Postmenopausal: estradiol < 0.20 nmol/l, Follicle stimulating hormone > 22 IU/l and progesterone 0.3-2.5 nmol/l

Exclusion Criteria:

  • Smoking
  • Excessive alcohol intake
  • Regular medication including hormone replacement treatment
  • Chronic disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Premenopausal women
The Premenopausal women are randomized to exercise by spinning (cycle)
After the baseline studies the pre and postmenopausal women will be randomized to spinning training groups and the intervention will last for 3 months. The spinning group will spin three times per week under guidance of a trained instructor. The training is heart rate monitored.
Experimental: Postmenopausal women
The Postmenopausal women are randomized to exercise by spinning (cycle)
After the baseline studies the pre and postmenopausal women will be randomized to spinning training groups and the intervention will last for 3 months. The spinning group will spin three times per week under guidance of a trained instructor. The training is heart rate monitored.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Leg vascular function
Time Frame: Baseline comparison and changes from baseline to 3 months
Measurements of leg blood flow by ultrasound doppler during exercise and during femoral arterial infusion of vasodilators
Baseline comparison and changes from baseline to 3 months
Cardiac structure and function
Time Frame: Baseline comparison and changes from baseline to 3 months
Magnetic resonance imaging and transthoracic echocardiography
Baseline comparison and changes from baseline to 3 months
Platelet function
Time Frame: Baseline comparison and changes from baseline to 3 months
Platelet aggregation assay of whole blood and platelet rich plasma
Baseline comparison and changes from baseline to 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Expression of proteins in muscle samples
Time Frame: Baseline comparison and changes from baseline to 3 months
Western Blot analysis of proteins of relevance for vascular function and metabolism
Baseline comparison and changes from baseline to 3 months
Maximal aerobic effect
Time Frame: Baseline comparison and changes from baseline to 3 months
Maximal oxygen uptake during an incremental cycle ergometry test with gas analysis
Baseline comparison and changes from baseline to 3 months
Genomic profile in blood samples
Time Frame: Baseline comparison and changes from baseline to 3 months
Genomic analysis of parameters for vascular and metabolic health
Baseline comparison and changes from baseline to 3 months
Insulin sensitivity and glycaemic control
Time Frame: Baseline comparison and changes from baseline to 3 months
Fasting plasma glucose analysis and oral glucose tolerance test
Baseline comparison and changes from baseline to 3 months
Arterial blood pressure
Time Frame: Baseline comparison and changes from baseline to 3 months
Baseline comparison and changes from baseline to 3 months
Gene expression of proteins in muscle samples
Time Frame: Baseline comparison and changes from baseline to 3 months
Gene analysis of relevance for vascular and metabolic function
Baseline comparison and changes from baseline to 3 months
Health related parameters in blood
Time Frame: Baseline comparison and changes from baseline to 3 months
Plasma lipid status and other variables related to vascular health
Baseline comparison and changes from baseline to 3 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anthropometry
Time Frame: Baseline comparison and changes from baseline to 3 months
Dual x-ray absorptiometry, height, weight, waist and hip circumference
Baseline comparison and changes from baseline to 3 months
Activity measure
Time Frame: Baseline comparison and changes from baseline to 3 months
Activity measure for one week by accelerometer
Baseline comparison and changes from baseline to 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Erik Richter, MD PhD, University of Copenhagen

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2014

Primary Completion (Actual)

July 1, 2017

Study Completion (Actual)

July 1, 2017

Study Registration Dates

First Submitted

April 1, 2014

First Submitted That Met QC Criteria

May 6, 2014

First Posted (Estimate)

May 12, 2014

Study Record Updates

Last Update Posted (Actual)

August 16, 2018

Last Update Submitted That Met QC Criteria

August 14, 2018

Last Verified

August 1, 2018

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Clinical Trials on Spinning

Subscribe